Physician profile
Charles C Peyton
NPI 1205195195
$27,125.23
in general payments reported to CMS, 2019-2025
19 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.90 · 2020: $3,192 · 2021: $191 · 2022: $1,104 · 2023: $517 · 2024: $11K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Honoraria: $4,000 · Food and Beverage: $2,295 · Travel and Lodging: $1,193 · Education: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,037.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Honoraria | $4,000.00 |
| Food and Beverage | $2,294.59 |
| Travel and Lodging | $1,193.41 |
| Education | $1,035.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $8,748.75 | 2022-2025 | |
| Boston Scientific Corporation | $4,415.28 | 2024-2025 | Ams 700, Lithovue |
| Intuitive Surgical, INC. | $3,692.37 | 2020-2024 | |
| Janssen Global Services, LLC | $2,691.14 | 2025 | |
| Ferring Pharmaceuticals INC. | $2,689.49 | 2024-2025 | Adstiladrin |
| Janssen Scientific Affairs, LLC | $1,608.76 | 2023-2025 | Erleada |
| Janssen Research & Development, LLC | $1,390.00 | 2022-2025 | |
| Coloplast Corp | $786.53 | 2021-2025 | Porges Coloplast, Titan |
| Angiodynamics, INC. | $434.35 | 2021-2022 | |
| Olympus America INC. | $135.59 | 2025 | Uretero-Reno Videoscope, Uropass |
| Janssen Biotech, INC. | $131.47 | 2025 | Rybrevant, Carvykti |
| Photocure INC | $89.05 | 2021-2022 | |
| Karl Storz Endoscopy-America | $87.16 | 2023 | Flex-X / Image 1 S |
| Astrazeneca Pharmaceuticals LP | $77.90 | 2019 | |
| Palette Life Sciences, INC. | $75.04 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $50.69 | 2025 | |
| Immunitybio, INC. | $21.66 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Peyton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.